Travere Therapeutics
TVTX
TVTX
113 hedge funds and large institutions have $1.03B invested in Travere Therapeutics in 2017 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 46 increasing their positions, 29 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
113
Holders Change
+5
Holders Change %
+4.63%
% of All Funds
2.82%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.12%
New
17
Increased
46
Reduced
29
Closed
11
Calls
$13.3M
Puts
$1.7M
Net Calls
+$11.6M
Net Calls Change
+$5.3M
Top Buyers
| 1 |
CCM
Consonance Capital Management
New York
|
+$26.6M |
| 2 |
SCM
Scopia Capital Management
New York
|
+$17.1M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$6.73M |
| 4 |
Millennium Management
New York
|
+$6.48M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
+$3.84M |
Top Sellers
| 1 |
BC
Broadfin Capital
New York
|
-$28.5M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$12.4M |
| 3 |
Jennison Associates
New York
|
-$7.53M |
| 4 |
ORI
Oak Ridge Investments
Chicago,
Illinois
|
-$7.05M |
| 5 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
-$5.47M |
